In this blog we are going to tell you about Patientportal aegislabs.com, so read this blog carefully to get the complete information.
In order to accurately establish whether a patient needs testing, AEGIS is urging that any of their patients who are reporting Covid-19 viral adverse symptoms consult their primary care physician first. Your PCP, who is the expert on you and your medical background, will want to take into account all factors.
In addition to enabling you to stay in your house while you’re feeling under the weather, testing at home also stops the spread of any germs around the neighborhood. From the moment tests are entered onto their research laboratory tracking system until test results are sent, the Aegis TAT is estimated. The time spent getting to the lab is excluded.
The TAT in the Aegis system is determined from the moment samples are entered into the lab tracking system to the moment test results are received. The calculation excludes the travel time to the lab. All of Aegis’ collection partners employ overnight shipment following collection. Shipping holdups and weekend shipping patterns may impact the duration between the collection event and the final Aegis report.
In order to increase the use of overnight transportation to its lab following collection, All Aegis collaborates with its collection partners. The interval between the collecting event and the final Aegis report may be impacted by shipping delays and end-of-week delivery schedules.
What is patientportal.aegislabs.com?
Aegis has the power to improve people’s lives. They accomplish this by offering precise, trustworthy, and useful data about patients’ medication adherence that enables healthcare professionals to give the best treatment.
The considerable public health risk that hazardous synthetic medicines pose is acknowledged by Aegis.
They use cutting-edge technology to continually test for the most pertinent new psychoactive substances and give a wide selection of analytes and medications that are currently on the market for providers to pick from.
The FLUIDTM platform from their company offers simple ordering and precise outcomes that put the solutions at your fingertips.
Standard electronic connectivity offered by Aegis FLUIDTM makes it easier to enter patient information, request tests, and get test results, which reduces mistakes and saves time.
Types Of COVID-19 Testing
- Molecular testing
RNA from the SARS-CoV-2 virus is found by molecular methods to determine if a COVID-19 infection is active or acute. Examples include loop-mediated isothermal amplification, the nucleic acid amplification test (NAAT), and real-time reverse transcription-polymerase chain reaction (RT-PCR) (LAMP). Nasopharyngeal, deep nasal, anterior nares, and oropharyngeal are all collecting routes. Results of molecular test experiments can be obtained in as little as three to four hours or as much as seven days, depending on the lab’s capability; the typical duration is one to two days.
- Antigen testing
In order to determine if an infection is active or acute, antigen assays look for surface proteins from the SARS-CoV-2 virus. Samples are taken from the front nares and nasopharynx. For those experiencing adverse symptoms during the first 5 to 7 days after infection, antigen testing are advised. A confirmatory RT-PCR test is advised because a Cochrane basic review of 22 antigen test investigations revealed that their sensitivity varied widely, from 0% to 94%, with the average sensitivity being 56.2%.
- Antibody testing
To find a prior infection, antibody testing—which needs blood drawn from a vein or a finger prick—is used.
Lateral flow or immunoassay assays, such as the ELISA (chemical-connected immunodeficiency examination) and the CIA, are used to conduct these tests (chemiluminescent immunoassay). Immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies generated in response to the illness can be detected using antibody testing.
Before use, the FDA does not formally evaluate the demonstration of immunizer tests that are not commercially advertised. Nevertheless, emergency use authorisation is needed for antibody tests that are marketed commercially.
Logging In To Patientportal.aegislabs.com
Aegis provides a portal to its customers to access their reports. When the sample has been received and the testing has started, the portal will show that this has happened. Results from the testing will eventually show up on the portal. As soon as your findings are available, you will also receive an email with them. To sign in, just visit https://clientportal.aegislabs.com/Home/Login?ReturnUrl=%2fSecure%2fDashboard and login with your username and password. To access Aegis COVID-19 Patient Portal visit https://clientportal.aegislabs.com/Covid/BeginSession and enter your Requisition Number and Collection Date to check on testing status.
Millions of people have become ill worldwide in the past year as a result of the spread of SARS-CoV-2. Healthcare professionals, epidemiologists, virologists, and laboratory scientists have faced a huge uphill struggle in preventing COVID-19’s spread and treating the individuals who are afflicted despite the fact that understanding about the virus that causes COVID-19 has increased dramatically.
Aegis Sciences Corporation has performed over 3 million tests to far and will continue to do so in order to give healthcare practitioners with highly sensitive and precise diagnostic test findings in a clinically appropriate turnaround time. In the midst of ongoing change across the Pandemic, certain groups of clinical and research centre experts will continue to monitor the logical writing and clinical testing recommendations.
Easy-to-Read Test Results are Provided
Regardless of the outcome, it has been demonstrated that patients prefer to obtain their test results through email via the patient portal.
Three-fourths of individuals polled claimed to have waited for test results at a doctor’s office or hospital for up to an hour, indicating that such procedures may take some time. Additionally, according to 31% of respondents, getting lab results—such as those from a COVID-19 test—reduces the likelihood that crucial clinical information would be missed. They can simply get the findings because they are stored on the site.
MANAGING A ORDERLY CALL CENTER
Of course, a patient reviewing the COVID-19 lab test results via the patient portal might still choose to call. Even if she tested negative, as mentioned above, he or she may not comprehend the results or may wish to inquire further about the next steps.
Some patients may have had trouble using the patient portal at all and have had to access it through the facility or hospital contact centre. A favourable patient experience will greatly benefit from keeping those channels open.
Numerous medical care associations used call centre automation during the underlying pandemic need to transport patients through the phone lines fast. Emergency patient questions can be helped by automation or mechanisation, and patients can access the appropriate kind of data. However, if a patient requires their COVID-19 test findings or outcomes, an automated innovation can also refer them to a contact centre employee and then a doctor. This may allow the contact centre staff to handle more calls more quickly while improving the patient experience.
Conclusion:-
The quick creation and progress of testing techniques, as well as the equivalent increase in knowledge, including the drawbacks and advantages of each methodology, have been motivated by the rising need for COVID-19 testing. Testing for the Coronavirus is a crucial component of public health measures to stop the infection’s spread. If you choose Aegis, you will get accurate and easy-to-understand test results.
